Malignant hyperthermia (MH) is a muscle genetic disorder that is triggered by common anesthetic agents. Although rare, if not recognized early, MH can lead to serious complications and possibly death while undergoing an operation. Our understanding of MH has improved over the years with the adoption of genetic sequencing, however, more work is needed to further understand which patients are at the highest risk of an MH crisis. Given the ubiquity of anesthesia worldwide and the consequences of not recognizing MH early, further understanding of MH and its risk factors has the potential to save lives. The study should take approximately 1-2 years to complete.
